The ankle–brachial index (ABI) measurement is widely used as a screening tool to detect peripheral arterial disease (PAD). With the advent of the oscillometric ABI device incorporating a system for ...

Combination therapy consisting of once-daily macitentan and tadalafil was associated with reductions in pulmonary vascular resistance in patients with pulmonary arterial hypertension. NEW ORLEANS – ...

Please provide your email address to receive an email when new articles are posted on . New data expand the range of pulmonary vascular resistance associated with mortality and heart failure in ...

Pulmonary arterial hypertension (PAH) is a rare disease in which the progressive narrowing of the lumen of pulmonary arteries leads to a rise in pulmonary arterial pressure and pulmonary vascular ...

Pulmonary arterial hypertension (PAH) is characterized by nonspecific symptoms, which can lead to a delay in diagnosis. Without treatment, patients with PAH have a poor prognosis, but development and ...

Sotatercept significantly reduces pulmonary vascular resistance in patients with CpcPH–HFpEF compared with placebo, according to a trial.

Expert Rev Resp Med. 2012;6(3):255-265. The acute effect of the combination oral sildenafil and inhaled treprostinil has also been assessed. Fifty patients with pulmonary hypertension of varying ...

WASHINGTON -- The novel investigational therapy seralutinib effectively reduced pulmonary vascular resistance (PVR) in patients with pulmonary arterial hypertension (PAH) on standard background ...